Slingshot members are tracking this event:
Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA (bendamustine hydrochloride) Injection
Do you think this event is important to the companies below? How will it affect their stock price?
Under a February 2015 exclusive license agreement for BENDEKA, Teva is responsible for all U.S. commercial activities for the product including promotion and distribution.
Slingshot Insights Explained
Jan 28, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Commercial Launch, Bendeka, Bendamustine Hydrochloride Injection, License Agreement, Distribution, Chlorambucil, B-cell Non-hodgkin Lymphoma, Nhl, Chronic Lymphocytic Leukemia, Cll